Wordt geladen...
Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
Immunotherapy has emerged as a major therapeutic modality in oncology. Currently, however, the majority of patients with cancer do not derive benefit from these treatments. Vascular abnormalities are a hallmark of most solid tumours and facilitate immune evasion. These abnormalities stem from elevat...
Bewaard in:
| Gepubliceerd in: | Nat Rev Clin Oncol |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5921900/ https://ncbi.nlm.nih.gov/pubmed/29508855 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrclinonc.2018.29 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|